Spyre Therapeutics Announces Grants of Inducement Awards
Spyre Therapeutics granted stock options to purchase 51,300 shares to four non-executive employees as equity inducement awards. The options carry an exercise price of $70.54, matching the June 1 closing price, and vest over four years with a 25% cliff.
Key figures
- Term years
- 10
- Exercise price
- 70.54
- Shares granted
- 51300
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.